Multivariate analysis of the survival rate for treatment modalities in incurable stage IV colorectal cancer

Journal of the Korean Society of Coloproctology

Volumn 28, Issue 1, 2012, Pages 35-41

  Kim, Sung Kang ^a   Lee, Chang Ho ^a   Lee, Min Ro ^a   Kim, Jong Hun ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Bypass; Colorectal cancer; Palliative; Stents

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BYPASS SURGERY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON HEMORRHAGE; COLORECTAL CANCER; COMPARATIVE STUDY; DEFECATION HABIT; FATALITY; FEMALE; HEART DISEASE; HISTOLOGY; HUMAN; ILEUS; INCURABLE COLORECTAL CANCER; LIVER METASTASIS; LUNG COMPLICATION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE ORGAN FAILURE; NAUSEA; PERITONEUM METASTASIS; POSTOPERATIVE CARE; SEPSIS; SURVIVAL RATE; SURVIVAL TIME;

EID: 84863610273     PISSN: 20937822     EISSN: 20937830     Source Type: Journal    
DOI: 10.3393/jksc.2012.28.1.35     Document Type: Article

References (29)

1. Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2008) and survival (1993-2008) in Korea. Seoul: Ministry for Health, Welfare and Family Affairs; 2010.
2. Schmiegel W, Pox C, Adler G, Fleig W, Fölsch UR, Frühmorgen P, et al. S3-Guidelines Conference "Colorectal Carcinoma" 2004. Z Gastroenterol 2004;42:1129-77. (Pubitemid 39486911)
3. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722-8. (Pubitemid 36560202)
4. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 1997;84:1731-6.
5. Mäkelä J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846-50. (Pubitemid 20350502)
6. Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer-is it worthwhile? Dis Colon Rectum 1997;40:11-4. (Pubitemid 27056392)
7. Beham A, Rentsch M, Püllmann K, Mantouvalou L, Spatz H, Schlitt HJ, et al. Survival benefit in patients after palliative resection vs non-resection colon cancer surgery. World J Gastroenterol 2006;12:6634-8. (Pubitemid 44794940)
8. Guba M, Bosserhoff AK, Steinbauer M, Abels C, Anthuber M, Buettner R, et al. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo. Br J Cancer 2000;83:1216-22.
9. Costi R, Mazzeo A, Di Mauro D, Veronesi L, Sansebastiano G, Violi V, et al. Palliative resection of colorectal cancer: does it prolong survival? Ann Surg Oncol 2007;14:2567-76. (Pubitemid 47389576)
10. Kleespies A, Füessl KE, Seeliger H, Eichhorn ME, Müller MH, Rentsch M, et al. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis 2009;24:1097-109.
11. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-47. (Pubitemid 30644117)
12. Cunningham D, Pyrhönen S, James RD, Punt CJ, Hickish TF, Heikkila R, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352:1413-8. (Pubitemid 28510874)
13. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42. (Pubitemid 38702844)
14. Kang DB, Shin CY, Lee JK, Park WC. Multivariate analysis of the risk factors associated with complications and mortality after and emergency operation for obstructive, perforated colorectal cancer. J Korean Soc Coloproctol 2009;25:165-71.
15. Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000;135:530-4.
16. Costi R, Di Mauro D, Giordano P, Leonardi F, Veronesi L, Sarli L, et al. Impact of palliative chemotherapy and surgery on management of stage IV incurable colorectal cancer. Ann Surg Oncol 2010;17:432-40.
17. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993;306:752-5. (Pubitemid 23080053)
18. Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 1987;5:1559-65. (Pubitemid 18010132)
19. Karoui M, Soprani A, Charachon A, Delbaldo C, Vigano L, Luciani A, et al. Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer. Eur J Surg Oncol 2010;36:58-64.
20. Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 2005;89:211-7. (Pubitemid 40333526)
21. Kim JH, Shon DH, Cahng BI, Chung MK, Shim MC. Complete single stage management of left colon cancer obstruction with a new devices. J Korean Soc Coloproctol 2002;18:30-6.
22. Kim JY, Kim JS, Hur H, Min BS, Kim NK, Sohn SK, et al. Complication and relevant factors after an ileostomy for fecal diversion in a patient with rectal cancer. J Korean Soc Coloproctol 2009;25:81-7.
23. Shin SJ, Kim TI, Kim BC, Lee YC, Song SY, Kim WH. Clinical application of self-expandable metallic stent for treatment of colorectal obstruction caused by extrinsic invasive tumors. Dis Colon Rectum 2008;51:578-83.
24. Bittinger M, Messmann H. Self-expanding metal stents as nonsurgical palliative therapy for malignant colonic obstruction: time to change the standard of care? Gastrointest Endosc 2007;66:928-30. (Pubitemid 47600189)
25. Lee KM, Shin SJ, Hwang JC, Cheong JY, Yoo BM, Lee KJ, et al. Comparison of uncovered stent with covered stent for treatment of malignant colorectal obstruction. Gastrointest Endosc 2007;66:931-6. (Pubitemid 47600166)
26. Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004;99:2051-7. (Pubitemid 39421255)
27. Meisner S, Hensler M, Knop FK, West F, Wille-Jørgensen P. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis Colon Rectum 2004;47:444-50. (Pubitemid 38436649)
28. Kim HH, Kim HK, Cho SH, Huh JW, Rhyu SY, Kim HR, et al. Usefulness of self-expandable metallic stents for malignant colon obstruction. J Korean Soc Coloproctol 2009;25:113-6.
29. Kim MS, Lim SW, Park SJ, Gwak G, Yang KH, Bae BN, et al. Survival rate and prognostic factors in perforated colorectal cancer patients: a case-control study. J Korean Soc Coloproctol 2010;26:69-75.